CN105753462A - Turtle type activated energy magnet therapy plate and preparation method thereof - Google Patents
Turtle type activated energy magnet therapy plate and preparation method thereof Download PDFInfo
- Publication number
- CN105753462A CN105753462A CN201610079513.5A CN201610079513A CN105753462A CN 105753462 A CN105753462 A CN 105753462A CN 201610079513 A CN201610079513 A CN 201610079513A CN 105753462 A CN105753462 A CN 105753462A
- Authority
- CN
- China
- Prior art keywords
- parts
- stone
- tremolite
- germanite
- trona
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002653 magnetic therapy Methods 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims description 8
- 241000270666 Testudines Species 0.000 title abstract 3
- 239000004575 stone Substances 0.000 claims abstract description 58
- 229910052613 tourmaline Inorganic materials 0.000 claims abstract description 20
- 229940070527 tourmaline Drugs 0.000 claims abstract description 20
- 239000011032 tourmaline Substances 0.000 claims abstract description 20
- 229910021532 Calcite Inorganic materials 0.000 claims abstract description 19
- 241000219109 Citrullus Species 0.000 claims abstract description 19
- 235000012828 Citrullus lanatus var citroides Nutrition 0.000 claims abstract description 19
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 19
- 241001625808 Trona Species 0.000 claims abstract description 19
- 229910021536 Zeolite Inorganic materials 0.000 claims abstract description 19
- 229910052934 alunite Inorganic materials 0.000 claims abstract description 19
- 239000010424 alunite Substances 0.000 claims abstract description 19
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims abstract description 19
- 239000010428 baryte Substances 0.000 claims abstract description 19
- 229910052601 baryte Inorganic materials 0.000 claims abstract description 19
- WUKWITHWXAAZEY-UHFFFAOYSA-L calcium difluoride Chemical compound [F-].[F-].[Ca+2] WUKWITHWXAAZEY-UHFFFAOYSA-L 0.000 claims abstract description 19
- NWXHSRDXUJENGJ-UHFFFAOYSA-N calcium;magnesium;dioxido(oxo)silane Chemical compound [Mg+2].[Ca+2].[O-][Si]([O-])=O.[O-][Si]([O-])=O NWXHSRDXUJENGJ-UHFFFAOYSA-N 0.000 claims abstract description 19
- 229910052637 diopside Inorganic materials 0.000 claims abstract description 19
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims abstract description 19
- 239000010436 fluorite Substances 0.000 claims abstract description 19
- 239000001095 magnesium carbonate Substances 0.000 claims abstract description 19
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims abstract description 19
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims abstract description 19
- 235000014380 magnesium carbonate Nutrition 0.000 claims abstract description 19
- 239000005332 obsidian Substances 0.000 claims abstract description 19
- 229910052903 pyrophyllite Inorganic materials 0.000 claims abstract description 19
- 229910052889 tremolite Inorganic materials 0.000 claims abstract description 19
- KPZTWMNLAFDTGF-UHFFFAOYSA-D trialuminum;potassium;hexahydroxide;disulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O KPZTWMNLAFDTGF-UHFFFAOYSA-D 0.000 claims abstract description 19
- 239000010457 zeolite Substances 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 14
- 239000003814 drug Substances 0.000 claims description 20
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 238000001125 extrusion Methods 0.000 claims description 5
- 238000010304 firing Methods 0.000 claims description 5
- 239000000463 material Substances 0.000 claims description 5
- 229940079593 drug Drugs 0.000 claims description 4
- 206010019345 Heat stroke Diseases 0.000 claims 1
- 230000036541 health Effects 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 5
- 241000251468 Actinopterygii Species 0.000 abstract 1
- 239000010440 gypsum Substances 0.000 abstract 1
- 229910052602 gypsum Inorganic materials 0.000 abstract 1
- 239000010455 vermiculite Substances 0.000 abstract 1
- 229910052902 vermiculite Inorganic materials 0.000 abstract 1
- 235000019354 vermiculite Nutrition 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 4
- 230000003796 beauty Effects 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 210000000653 nervous system Anatomy 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 208000026137 Soft tissue injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000003851 biochemical process Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007160 gastrointestinal dysfunction Effects 0.000 description 1
- 201000011066 hemangioma Diseases 0.000 description 1
- 238000002169 hydrotherapy Methods 0.000 description 1
- 230000032630 lymph circulation Effects 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B35/00—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products
- C04B35/01—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics
- C04B35/16—Shaped ceramic products characterised by their composition; Ceramics compositions; Processing powders of inorganic compounds preparatory to the manufacturing of ceramic products based on oxide ceramics based on silicates other than clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3205—Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
- C04B2235/3206—Magnesium oxides or oxide-forming salts thereof
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3205—Alkaline earth oxides or oxide forming salts thereof, e.g. beryllium oxide
- C04B2235/3208—Calcium oxide or oxide-forming salts thereof, e.g. lime
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/32—Metal oxides, mixed metal oxides, or oxide-forming salts thereof, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3217—Aluminum oxide or oxide forming salts thereof, e.g. bauxite, alpha-alumina
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/34—Non-metal oxides, non-metal mixed oxides, or salts thereof that form the non-metal oxides upon heating, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3427—Silicates other than clay, e.g. water glass
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/34—Non-metal oxides, non-metal mixed oxides, or salts thereof that form the non-metal oxides upon heating, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3427—Silicates other than clay, e.g. water glass
- C04B2235/3436—Alkaline earth metal silicates, e.g. barium silicate
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/34—Non-metal oxides, non-metal mixed oxides, or salts thereof that form the non-metal oxides upon heating, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/3427—Silicates other than clay, e.g. water glass
- C04B2235/3463—Alumino-silicates other than clay, e.g. mullite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/34—Non-metal oxides, non-metal mixed oxides, or salts thereof that form the non-metal oxides upon heating, e.g. carbonates, nitrates, (oxy)hydroxides, chlorides
- C04B2235/349—Clays, e.g. bentonites, smectites such as montmorillonite, vermiculites or kaolines, e.g. illite, talc or sepiolite
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/44—Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
- C04B2235/444—Halide containing anions, e.g. bromide, iodate, chlorite
- C04B2235/445—Fluoride containing anions, e.g. fluosilicate
-
- C—CHEMISTRY; METALLURGY
- C04—CEMENTS; CONCRETE; ARTIFICIAL STONE; CERAMICS; REFRACTORIES
- C04B—LIME, MAGNESIA; SLAG; CEMENTS; COMPOSITIONS THEREOF, e.g. MORTARS, CONCRETE OR LIKE BUILDING MATERIALS; ARTIFICIAL STONE; CERAMICS; REFRACTORIES; TREATMENT OF NATURAL STONE
- C04B2235/00—Aspects relating to ceramic starting mixtures or sintered ceramic products
- C04B2235/02—Composition of constituents of the starting material or of secondary phases of the final product
- C04B2235/30—Constituents and secondary phases not being of a fibrous nature
- C04B2235/44—Metal salt constituents or additives chosen for the nature of the anions, e.g. hydrides or acetylacetonate
- C04B2235/448—Sulphates or sulphites
Abstract
The invention discloses a turtle type activated energy magnet therapy plate, prepared from the following raw materials: stone needle, tourmaline stone, medical stone, germanite, wooden fish stone, obsidian, watermelon tourmaline, Lingcao amber, gypsum, pyrophyllite, diopside, tremolite, vermiculite, zeolite, alunite, barite, trona, calcite, iceland spar, magnesite and fluorite. The turtle type activated energy magnet therapy plate is convenient to use, high in safety and wide in application range, and has functions of protecting home health, preventing and treating diseases, prolonging life, beautifying and maintaining health.
Description
Technical field
The present invention relates to a kind of Cheloniform active-energy magnetic therapy plate and preparation method thereof.
Background technology
Magnetic therapy is in the method for human disease treatment with the action of a magnetic field.Magnetic field affects the magnetic moment orientation etc. of body current distribution, the motion of Charge particle, the permeability of membranous system and biopolymer, makes histiocytic physiology, biochemical process change, and produces analgesia, detumescence, promotes the effect such as blood and lymph circulation.The common method of magnetic therapy has: 1. magnetostatic therapy.For acupuncture point and pathological changes local.2. dynamic magnetotherapy.Also known as gyromagnet and pulsation magnetotherapy.3. magnetic hydro-therapy and magnetic needle therapy etc..Clinical conventional to treat soft tissue injury, the shallow hemangioma of table, cyclomastopathy, neuralgia, gastrointestinal dysfunction etc..
Current existing magnetic therapy plate in-convenience in use, therapeutic effect is notable, and health-care effect does not highlight.
Summary of the invention
The technical problem to be solved in the present invention is to provide a kind of easy to use, safe and has wide range of applications, and has a household health care, preventing and treating diseases, life lengthening, beauty and health care the Cheloniform active-energy magnetic therapy plate of effect.
For solving the problems referred to above, the present invention adopts the following technical scheme that
nullA kind of Cheloniform active-energy magnetic therapy plate，Including following raw material: stone needle、Tourmaline stone、Maifanitum、Germanite、Muyu-Stone、Obsidian、Watermelon tourmalin、Medicine amber、Gypsum Fibrosum、Pyrophyllite、Diopside、The tremolite、Vermiculitum、Zeolite、Alunite、Barite、Trona、Calcite、Iceland spar、Magnesite and fluorite，Described raw material is made up of following mass fraction proportioning: stone needle 15-20 part、Tourmaline stone 20-24 part、Maifanitum 8-12 part、Germanite 9-15 part、Muyu-Stone 8-10 part、Obsidian 13-16 part、Watermelon tourmalin 7-10 part、Medicine amber 2-4 part、Gypsum Fibrosum 3-6 part、Pyrophyllite 6-9 part、Diopside 13-15 part、Tremolite 17-20 part、Vermiculitum 5-10 part、Zeolite 4-8 part、Alunite 3-5 part、Barite 6-10 part、Trona 11-14 part、Calcite 12-16 part、Iceland spar 18-20 part、Magnesite 11-14 part and fluorite 22-24 part.
Further, described raw material is made up of following mass fraction proportioning: stone needle 15 parts, 20 parts of tourmaline stone, Maifanitum 8 parts, germanite 9 parts, Muyu-Stone 8 parts, obsidian 13 parts, Watermelon tourmalin 7 parts, medicine amber 2 parts, 3 parts of Gypsum Fibrosum, pyrophyllite 6 parts, diopside 13 parts, the tremolite 17 parts, Vermiculitum 5 parts, 4 parts of zeolite, alunite 3 parts, 6 parts of barite, 11 parts of trona, 12 parts of calcite, Iceland spar 18 parts, 11 parts of magnesite and 22 parts of fluorite.
Further, described raw material is made up of following mass fraction proportioning: stone needle 17.5 parts, 22 parts of tourmaline stone, Maifanitum 10 parts, germanite 12 parts, Muyu-Stone 9 parts, obsidian 14.5 parts, Watermelon tourmalin 8.5 parts, medicine amber 3 parts, 4.5 parts of Gypsum Fibrosum, pyrophyllite 7.5 parts, diopside 14 parts, the tremolite 18.5 parts, Vermiculitum 7.5 parts, 6 parts of zeolite, alunite 4 parts, 8 parts of barite, 12.5 parts of trona, 14 parts of calcite, Iceland spar 19 parts, 12.5 parts of magnesite and 23 parts of fluorite.
Further, described raw material is made up of following mass fraction proportioning: stone needle 20 parts, 24 parts of tourmaline stone, Maifanitum 12 parts, germanite 15 parts, Muyu-Stone 10 parts, obsidian 16 parts, Watermelon tourmalin 10 parts, medicine amber 4 parts, 6 parts of Gypsum Fibrosum, pyrophyllite 9 parts, diopside 15 parts, the tremolite 20 parts, Vermiculitum 10 parts, 8 parts of zeolite, alunite 5 parts, 10 parts of barite, 14 parts of trona, 16 parts of calcite, Iceland spar 20 parts, 14 parts of magnesite and 24 parts of fluorite.
The preparation method that another technical problem that the invention solves the problems that is to provide a kind of Cheloniform active-energy magnetic therapy plate, comprises the following steps:
1) stone needle 15-20 part, tourmaline stone 20-24 part, Maifanitum 8-12 part, germanite 9-15 part, Muyu-Stone 8-10 part, obsidian 13-16 part, Watermelon tourmalin 7-10 part, medicine amber 2-4 part, Gypsum Fibrosum 3-6 part, pyrophyllite 6-9 part, diopside 13-15 part, tremolite 17-20 part, Vermiculitum 5-10 part, zeolite 4-8 part, alunite 3-5 part, barite 6-10 part, trona 11-14 part, calcite 12-16 part, Iceland spar 18-20 part, magnesite 11-14 part and fluorite 22-24 part are mixed, grind into powder；
2) powder is mixed with clear water, with the hands crumple, or tramp with one's feet and step on, the air extrusion in walk out, and make the uniform moisture in mud, make blank；
3) blank is pressed in forming machine tabular, is placed on yoke and dries；
4) by step 3) resulting materials is through the high-temperature firing of more than 1000 DEG C.
The invention has the beneficial effects as follows: utilize pottery just hindering coefficient resister principle, it is combined with the electromagnetic wave benefiting health and can penetrate the epidermis of human body, connective tissue, blood vessel and nervous system etc. with far infrared in local irradiation, energy can be absorbed by biological cell immediately, produce resonance, cause the thermogenetic effect of tissue, strengthen the vibration of human-body biological cellular water molecule, activating cell tissue, excite the mediation function of liver, dirty, muscular tissue, reach the effect of beauty treatment weight reducing, health protection health preserving.
Detailed description of the invention
Embodiment 1:
A kind of Cheloniform active-energy magnetic therapy plate, described raw material is made up of following mass fraction proportioning: stone needle 15 parts, 20 parts of tourmaline stone, Maifanitum 8 parts, germanite 9 parts, Muyu-Stone 8 parts, obsidian 13 parts, Watermelon tourmalin 7 parts, medicine amber 2 parts, 3 parts of Gypsum Fibrosum, pyrophyllite 6 parts, diopside 13 parts, the tremolite 17 parts, Vermiculitum 5 parts, 4 parts of zeolite, alunite 3 parts, 6 parts of barite, 11 parts of trona, 12 parts of calcite, Iceland spar 18 parts, 11 parts of magnesite and 22 parts of fluorite.
The preparation method of a kind of Cheloniform active-energy magnetic therapy plate, comprises the following steps:
1) by stone needle 15 parts, 20 parts of tourmaline stone, Maifanitum 8 parts, germanite 9 parts, Muyu-Stone 8 parts, obsidian 13 parts, Watermelon tourmalin 7 parts, medicine amber 2 parts, 3 parts of Gypsum Fibrosum, pyrophyllite 6 parts, diopside 13 parts, the tremolite 17 parts, Vermiculitum 5 parts, 4 parts of zeolite, alunite 3 parts, 6 parts of barite, 11 parts of trona, 12 parts of calcite, Iceland spar 18 parts, 11 parts of magnesite and the mixing of 22 parts of fluorite, grind into powder；
2) powder is mixed with clear water, with the hands crumple, or tramp with one's feet and step on, the air extrusion in walk out, and make the uniform moisture in mud, make blank；
3) blank is pressed in forming machine tabular, is placed on yoke and dries；
4) by step 3) resulting materials is through the high-temperature firing of more than 1000 DEG C.
Embodiment 2:
A kind of Cheloniform active-energy magnetic therapy plate, described raw material is made up of following mass fraction proportioning: stone needle 17.5 parts, 22 parts of tourmaline stone, Maifanitum 10 parts, germanite 12 parts, Muyu-Stone 9 parts, obsidian 14.5 parts, Watermelon tourmalin 8.5 parts, medicine amber 3 parts, 4.5 parts of Gypsum Fibrosum, pyrophyllite 7.5 parts, diopside 14 parts, the tremolite 18.5 parts, Vermiculitum 7.5 parts, 6 parts of zeolite, alunite 4 parts, 8 parts of barite, 12.5 parts of trona, 14 parts of calcite, Iceland spar 19 parts, 12.5 parts of magnesite and 23 parts of fluorite.
The preparation method of a kind of Cheloniform active-energy magnetic therapy plate, comprises the following steps:
1) by stone needle 17.5 parts, 22 parts of tourmaline stone, Maifanitum 10 parts, germanite 12 parts, Muyu-Stone 9 parts, obsidian 14.5 parts, Watermelon tourmalin 8.5 parts, medicine amber 3 parts, 4.5 parts of Gypsum Fibrosum, pyrophyllite 7.5 parts, diopside 14 parts, the tremolite 18.5 parts, Vermiculitum 7.5 parts, 6 parts of zeolite, alunite 4 parts, 8 parts of barite, 12.5 parts of trona, 14 parts of calcite, Iceland spar 19 parts, 12.5 parts of magnesite and the mixing of 23 parts of fluorite, grind into powder；
2) powder is mixed with clear water, with the hands crumple, or tramp with one's feet and step on, the air extrusion in walk out, and make the uniform moisture in mud, make blank；
3) blank is pressed in forming machine tabular, is placed on yoke and dries；
4) by step 3) resulting materials is through the high-temperature firing of more than 1000 DEG C.
Embodiment 3:
A kind of Cheloniform active-energy magnetic therapy plate, described raw material is made up of following mass fraction proportioning: stone needle 20 parts, 24 parts of tourmaline stone, Maifanitum 12 parts, germanite 15 parts, Muyu-Stone 10 parts, obsidian 16 parts, Watermelon tourmalin 10 parts, medicine amber 4 parts, 6 parts of Gypsum Fibrosum, pyrophyllite 9 parts, diopside 15 parts, the tremolite 20 parts, Vermiculitum 10 parts, 8 parts of zeolite, alunite 5 parts, 10 parts of barite, 14 parts of trona, 16 parts of calcite, Iceland spar 20 parts, 14 parts of magnesite and 24 parts of fluorite.
The preparation method of a kind of Cheloniform active-energy magnetic therapy plate, comprises the following steps:
1) by stone needle 20 parts, 24 parts of tourmaline stone, Maifanitum 12 parts, germanite 15 parts, Muyu-Stone 10 parts, obsidian 16 parts, Watermelon tourmalin 10 parts, medicine amber 4 parts, 6 parts of Gypsum Fibrosum, pyrophyllite 9 parts, diopside 15 parts, the tremolite 20 parts, Vermiculitum 10 parts, 8 parts of zeolite, alunite 5 parts, 10 parts of barite, 14 parts of trona, 16 parts of calcite, Iceland spar 20 parts, 14 parts of magnesite and the mixing of 24 parts of fluorite, grind into powder；
2) powder is mixed with clear water, with the hands crumple, or tramp with one's feet and step on, the air extrusion in walk out, and make the uniform moisture in mud, make blank；
3) blank is pressed in forming machine tabular, is placed on yoke and dries；
4) by step 3) resulting materials is through the high-temperature firing of more than 1000 DEG C.
Experimental example:
Experimental subject: crowd bad for 150 body constitution is randomly divided into 3 groups: matched group one, matched group two and experimental group, often organizes 50 people.
Test method: matched group one does not use medicine to treat, the common magnetic therapy plate of matched group dual-purpose is treated, and experimental group is treated by the Cheloniform active-energy magnetic therapy plate of the present invention.
Criterion:
Invalid: discomfort easily occurs in health, it is easy to disease occurs, and body constitution is bad.
Effect is general: discomfort easily occurs in health, it is easy to disease occurs, and body constitution is bad etc. is eased.
Effect is notable: without ill symptoms.
The experimental subject of 3 groups effectiveness comparison after a week, result is shown in following table:
By 3 groups of experiments are checked, the Cheloniform active-energy magnetic therapy plate of the present invention compared with common magnetic therapy, more remarkable effect.
The invention has the beneficial effects as follows: utilize pottery just hindering coefficient resister principle, it is combined with the electromagnetic wave benefiting health and can penetrate the epidermis of human body, connective tissue, blood vessel and nervous system etc. with far infrared in local irradiation, energy can be absorbed by biological cell immediately, produce resonance, cause the thermogenetic effect of tissue, strengthen the vibration of human-body biological cellular water molecule, activating cell tissue, excite the mediation function of liver, dirty, muscular tissue, reach the effect of beauty treatment weight reducing, health protection health preserving.
The above, be only the specific embodiment of the present invention, but protection scope of the present invention be not limited thereto, any change expected without creative work or replacement, all should be encompassed in protection scope of the present invention.
Claims (5)
- null1. a Cheloniform active-energy magnetic therapy plate，It is characterized in that，Including following raw material: stone needle、Tourmaline stone、Maifanitum、Germanite、Muyu-Stone、Obsidian、Watermelon tourmalin、Medicine amber、Gypsum Fibrosum、Pyrophyllite、Diopside、The tremolite、Vermiculitum、Zeolite、Alunite、Barite、Trona、Calcite、Iceland spar、Magnesite and fluorite，Described raw material is made up of following mass fraction proportioning: stone needle 15-20 part、Tourmaline stone 20-24 part、Maifanitum 8-12 part、Germanite 9-15 part、Muyu-Stone 8-10 part、Obsidian 13-16 part、Watermelon tourmalin 7-10 part、Medicine amber 2-4 part、Gypsum Fibrosum 3-6 part、Pyrophyllite 6-9 part、Diopside 13-15 part、Tremolite 17-20 part、Vermiculitum 5-10 part、Zeolite 4-8 part、Alunite 3-5 part、Barite 6-10 part、Trona 11-14 part、Calcite 12-16 part、Iceland spar 18-20 part、Magnesite 11-14 part and fluorite 22-24 part.
- 2. a kind of Cheloniform active-energy magnetic therapy plate as claimed in claim 1, it is characterized in that, described raw material is made up of following mass fraction proportioning: stone needle 15 parts, 20 parts of tourmaline stone, Maifanitum 8 parts, germanite 9 parts, Muyu-Stone 8 parts, obsidian 13 parts, Watermelon tourmalin 7 parts, medicine amber 2 parts, 3 parts of Gypsum Fibrosum, pyrophyllite 6 parts, diopside 13 parts, the tremolite 17 parts, Vermiculitum 5 parts, 4 parts of zeolite, alunite 3 parts, 6 parts of barite, 11 parts of trona, 12 parts of calcite, Iceland spar 18 parts, 11 parts of magnesite and 22 parts of fluorite.
- 3. a kind of Cheloniform active-energy magnetic therapy plate as claimed in claim 1, it is characterized in that, described raw material is made up of following mass fraction proportioning: stone needle 17.5 parts, 22 parts of tourmaline stone, Maifanitum 10 parts, germanite 12 parts, Muyu-Stone 9 parts, obsidian 14.5 parts, Watermelon tourmalin 8.5 parts, medicine amber 3 parts, 4.5 parts of Gypsum Fibrosum, pyrophyllite 7.5 parts, diopside 14 parts, the tremolite 18.5 parts, Vermiculitum 7.5 parts, 6 parts of zeolite, alunite 4 parts, 8 parts of barite, 12.5 parts of trona, 14 parts of calcite, Iceland spar 19 parts, 12.5 parts of magnesite and 23 parts of fluorite.
- 4. a kind of Chinese medicine treating pet dog heatstroke as claimed in claim 1, it is characterized in that, described raw material is made up of following mass fraction proportioning: stone needle 20 parts, 24 parts of tourmaline stone, Maifanitum 12 parts, germanite 15 parts, Muyu-Stone 10 parts, obsidian 16 parts, Watermelon tourmalin 10 parts, medicine amber 4 parts, 6 parts of Gypsum Fibrosum, pyrophyllite 9 parts, diopside 15 parts, the tremolite 20 parts, Vermiculitum 10 parts, 8 parts of zeolite, alunite 5 parts, 10 parts of barite, 14 parts of trona, 16 parts of calcite, Iceland spar 20 parts, 14 parts of magnesite and 24 parts of fluorite.
- 5. the preparation method of a Cheloniform active-energy magnetic therapy plate, it is characterised in that comprise the following steps:1) stone needle 15-20 part, tourmaline stone 20-24 part, Maifanitum 8-12 part, germanite 9-15 part, Muyu-Stone 8-10 part, obsidian 13-16 part, Watermelon tourmalin 7-10 part, medicine amber 2-4 part, Gypsum Fibrosum 3-6 part, pyrophyllite 6-9 part, diopside 13-15 part, tremolite 17-20 part, Vermiculitum 5-10 part, zeolite 4-8 part, alunite 3-5 part, barite 6-10 part, trona 11-14 part, calcite 12-16 part, Iceland spar 18-20 part, magnesite 11-14 part and fluorite 22-24 part are mixed, grind into powder；2) powder is mixed with clear water, with the hands crumple, or tramp with one's feet and step on, the air extrusion in walk out, and make the uniform moisture in mud, make blank；3) blank is pressed in forming machine tabular, is placed on yoke and dries；4) by step 3) resulting materials is through the high-temperature firing of more than 1000 DEG C.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610079513.5A CN105753462A (en) | 2016-02-04 | 2016-02-04 | Turtle type activated energy magnet therapy plate and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610079513.5A CN105753462A (en) | 2016-02-04 | 2016-02-04 | Turtle type activated energy magnet therapy plate and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105753462A true CN105753462A (en) | 2016-07-13 |
Family
ID=56330634
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610079513.5A Pending CN105753462A (en) | 2016-02-04 | 2016-02-04 | Turtle type activated energy magnet therapy plate and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105753462A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106519305A (en) * | 2016-10-21 | 2017-03-22 | 青岛首创嘉业工贸有限公司 | Active shoes and insoles and manufacturing method thereof |
| CN110357574A (en) * | 2019-07-12 | 2019-10-22 | 罗燕春 | A kind of magnetic therapy stone material and preparation method thereof |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066049A (en) * | 1991-04-22 | 1992-11-11 | 深圳新世纪饮水科技有限公司 | Maifanshi sintered material and preparation method thereof |
| CN103880402A (en) * | 2012-12-19 | 2014-06-25 | 辽宁法库陶瓷工程技术研究中心 | Preparation method for high-emissivity far-infrared health-care purple-sand porcelain slice |
| CN103951399A (en) * | 2014-04-08 | 2014-07-30 | 安徽省亚欧陶瓷有限责任公司 | Stone needle ceramic tile and preparation method thereof |
| CN105288862A (en) * | 2015-10-28 | 2016-02-03 | 天津市晨洁华美科技发展有限公司 | Far-infrared magnetic therapy card |
-
2016
- 2016-02-04 CN CN201610079513.5A patent/CN105753462A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1066049A (en) * | 1991-04-22 | 1992-11-11 | 深圳新世纪饮水科技有限公司 | Maifanshi sintered material and preparation method thereof |
| CN103880402A (en) * | 2012-12-19 | 2014-06-25 | 辽宁法库陶瓷工程技术研究中心 | Preparation method for high-emissivity far-infrared health-care purple-sand porcelain slice |
| CN103951399A (en) * | 2014-04-08 | 2014-07-30 | 安徽省亚欧陶瓷有限责任公司 | Stone needle ceramic tile and preparation method thereof |
| CN105288862A (en) * | 2015-10-28 | 2016-02-03 | 天津市晨洁华美科技发展有限公司 | Far-infrared magnetic therapy card |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106519305A (en) * | 2016-10-21 | 2017-03-22 | 青岛首创嘉业工贸有限公司 | Active shoes and insoles and manufacturing method thereof |
| CN110357574A (en) * | 2019-07-12 | 2019-10-22 | 罗燕春 | A kind of magnetic therapy stone material and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105797279B (en) | Multifunctional far infrared negative ions magnet therapy silica gel beauty care device and mating cosmetics | |
| CN109568194A (en) | A kind of Liquid bathing preparation made from light yellow sophora root and preparation method | |
| CN105753462A (en) | Turtle type activated energy magnet therapy plate and preparation method thereof | |
| CN107375252A (en) | A kind of Novel moxibustion patch and moxa-moxibustion patch combination | |
| CN106727687A (en) | A kind of beauty and health care material based on far-infrared technique and preparation method thereof | |
| CN1876121A (en) | A medicinal wine capable of treating multiple diseases | |
| CN106810248B (en) | A kind of antibacterial lavipeditum ball and preparation method thereof | |
| CN1237951C (en) | Microwave heat physiotherapeutic bay and its material making method | |
| CN102701717A (en) | Stone needle-based composite material and preparation method thereof | |
| CN105771091B (en) | A kind of anion patch composition | |
| CN103230462B (en) | Pain tincture for physiotherapeutic transdermal absorption and treatment of acute and chronic pains | |
| CN104524061A (en) | Ore plant compound powder used for multiple kinds of health care products and preparation method thereof | |
| CN1277033A (en) | Medicine for treating benign goiter | |
| CN202961143U (en) | Meridian conditioning device capable of being fastened in taking of user and fastening belt thereof | |
| CN110627477A (en) | Inorganic wide wave far infrared composite environment-friendly material | |
| CN104825653A (en) | Medicinal liquor for treating rheumatism and preparation method thereof | |
| CN108175949B (en) | A kind of physical therapy material and preparation method thereof | |
| CN104257719A (en) | Multi-purpose Chinese and western medicine ointment with swelling reducing and stagnation dissipating functions and preparation method of ointment | |
| CN202105225U (en) | Warm scraping and warm moxibustion cup with acupoint conical points | |
| CN108033767A (en) | A kind of nano biological health composite material and preparation method thereof | |
| CN1071581C (en) | Medicinal, magnetic and physiotherapeutic belt for foot | |
| CN201410232Y (en) | Warming ball | |
| CN107233421A (en) | Lavipeditum powder prepared by a kind of utilization bunge pricklyash root branch extract and preparation method thereof | |
| CN101623307A (en) | Emulsion for decreasing swelling, resisting spasm and relieving pain and preparation method thereof | |
| CN101912411A (en) | Stone needle health care spray |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160713 |
|
| RJ01 | Rejection of invention patent application after publication |